Privia Health Group (NASDAQ:PRVA) Given New $35.00 Price Target at Canaccord Genuity Group

Privia Health Group (NASDAQ:PRVA) had its price objective lifted by Canaccord Genuity Group from $34.00 to $35.00 in a report released on Friday,Benzinga reports. They currently have a buy rating on the stock.

PRVA has been the topic of several other reports. Citigroup restated a “market outperform” rating on shares of Privia Health Group in a report on Tuesday, January 6th. Evercore raised their price objective on shares of Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Stephens reiterated an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research note on Thursday, December 4th. Jefferies Financial Group restated a “buy” rating and set a $32.00 price target on shares of Privia Health Group in a research note on Thursday. Finally, JPMorgan Chase & Co. upped their price objective on Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $30.79.

Privia Health Group Trading Down 4.7%

PRVA stock traded down $1.16 during trading on Friday, hitting $23.75. The company had a trading volume of 1,803,550 shares, compared to its average volume of 792,446. Privia Health Group has a one year low of $18.77 and a one year high of $26.51. The business has a 50-day moving average of $23.07 and a 200-day moving average of $23.46. The stock has a market cap of $2.92 billion, a PE ratio of 139.71, a PEG ratio of 1.72 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.04 by $0.21. The company had revenue of $541.17 million during the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.12%. The company’s quarterly revenue was up 17.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. Research analysts forecast that Privia Health Group will post 0.14 EPS for the current year.

Insider Buying and Selling

In related news, Director Matthew Shawn Morris sold 13,647 shares of Privia Health Group stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total value of $341,311.47. Following the transaction, the director owned 68,188 shares in the company, valued at $1,705,381.88. This trade represents a 16.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO David Mountcastle sold 23,887 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the transaction, the chief financial officer directly owned 172,909 shares in the company, valued at $4,327,912.27. This trade represents a 12.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 10.70% of the stock is owned by company insiders.

Institutional Trading of Privia Health Group

A number of institutional investors have recently modified their holdings of the company. Hantz Financial Services Inc. raised its holdings in Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares in the last quarter. Global Retirement Partners LLC increased its position in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after buying an additional 1,351 shares during the period. CWM LLC raised its stake in Privia Health Group by 89.4% in the second quarter. CWM LLC now owns 3,416 shares of the company’s stock worth $79,000 after buying an additional 1,612 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in Privia Health Group in the fourth quarter worth about $93,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

More Privia Health Group News

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Q4 and full‑year 2025 results beat expectations and management delivered bullish 2026 guidance — revenue, EPS and adjusted EBITDA came in above guidance with adjusted EBITDA up strongly Y/Y and management guiding ~20% adjusted EBITDA growth (midpoint) and expansion to 24 states. This is the main fundamental driver supporting upside. GlobeNewswire
• Positive Sentiment: Analyst optimism: Canaccord recently raised its PRVA price target (to $35) and the mean analyst target implies material upside; several outlets highlight a consensus uplift in price targets — supportive for further analyst‑driven buying. Canaccord / Benzinga coverage
• Positive Sentiment: Company guidance emphasizes converting ~80% of adjusted EBITDA to free cash flow and ending 2026 with ~ $600M cash, plus no debt — balance‑sheet strength that can underwrite organic growth or M&A. MSN / coverage of guidance
• Neutral Sentiment: Supporting disclosure and materials: transcript and slide deck from the earnings call are available for deeper read — useful for modeling cadence of revenue/EBITDA conversions and provider growth assumptions. Earnings transcript (Yahoo)
• Negative Sentiment: Offset risks: large non‑cash stock‑based compensation ($71.1M in 2025), management’s note that forward non‑GAAP measures aren’t reconciled to GAAP (adding forecasting uncertainty), and disclosure of insider sales in recent months — items that can temper investor enthusiasm. QuiverQuant / release summary
• Negative Sentiment: Valuation and market action: PRVA trades at a high trailing P/E and the stock is seeing elevated volume today — likely profit‑taking or rotation despite the beat. That dynamic, plus at least one lower analyst target in the mix historically, helps explain short‑term downward pressure.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.